Atypical antipsychotics for acute agitation
- 1 December 2002
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 112 (6) , 85-96
- https://doi.org/10.3810/pgm.2002.12.1369
Abstract
The newer, atypical antipsychotics are better tolerated than the older neuroleptics. The intramuscular formulations of these drugs are useful in behavioral emergencies, when oral dosing is impractical. In addition, they provide a smooth transition to oral dosing with the same agent once the acute agitation has been managed. In this article, Dr Citrome discusses patient assessment, selection of an agent, and future possibilities for improved control.Keywords
This publication has 15 references indexed in Scilit:
- Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in SchizophreniaAmerican Journal of Psychiatry, 2001
- New onset diabetes and atypical antipsychoticsEuropean Neuropsychopharmacology, 2001
- Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.The Journal of Clinical Psychiatry, 2001
- Intramuscular Ziprasidone Compared With Intramuscular Haloperidol in the Treatment of Acute PsychosisThe Journal of Clinical Psychiatry, 2000
- Atypical antipsychotics and weightgain — a systematic reviewActa Psychiatrica Scandinavica, 2000
- VIOLENT PATIENTS IN THE EMERGENCY SETTINGPsychiatric Clinics of North America, 1999
- Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concernsSchizophrenia Research, 1999
- New antipsychotic medicationsPostgraduate Medicine, 1997
- INTRAMUSCULAR LORAZEPAM TO RESTRAIN VIOLENT PATIENTSThe Lancet, 1986
- Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral LorazepamJournal of Pharmaceutical Sciences, 1982